AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INCYTE CORP Director's Dealing 2024

Jan 22, 2024

30371_dirs_2024-01-22_039c8999-1aa5-4805-b955-47b54f135a4f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2024-01-18

Reporting Person: Stein Steven H (EVP & Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-18	Employee Stock Option (right to buy)	$61.18	A	30580	Acquired	2034-01-17	Common Stock (30580)	Direct

Footnotes

F1: Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.